TG Therapeutics (TGTX) Competitor Comparison
We are evaluating the key criteria listed to compare TG Therapeutics (TGTX) against its competitors in the Biotechnology industry.
Market Capitalization
79 / 368Gross Profits
116 / 278Total Revenue
61 / 300EBITDA
77 / 337Free Cashflow
188 / 352Quick Ratio
194 / 357Earnings per Share
47 / 359Dividend yield
0 / 6Total Cash
140 / 358Performance 3 years
89 / 368Performance 5 years
32 / 368Performance 10 years
53 / 368Linearity 3 years
93 / 368Linearity 5 years
327 / 368Linearity 10 years
325 / 368Total Rank
360 / 368Dividend Rank
288 / 368Valuation Rank
238 / 368Piotroski Rank
314 / 368Muliplier Rank
219 / 368Gross Profits - TGTX ranking 116 / 278
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.